• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于离线DPPH超高效液相色谱Q-萃取轨道阱质谱联用技术的补肺益肾方化学鉴定及抗氧化筛选

Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS.

作者信息

Wu Jinyan, Cai Bangrong, Zhang Ang, Zhao Peng, Du Yan, Liu Xuefang, Zhao Di, Yang Liu, Liu Xinguang, Li Jiansheng

机构信息

Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province & Education Ministry of China, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, China.

Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou, China.

出版信息

Int J Anal Chem. 2022 Oct 15;2022:1423801. doi: 10.1155/2022/1423801. eCollection 2022.

DOI:10.1155/2022/1423801
PMID:36284795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9588378/
Abstract

Chronic obstructive pulmonary disease (COPD) has high morbidity and mortality and presents a threat to human health worldwide. Numerous clinical trials have confirmed that Bufei Yishen formula (BYF), an herbal medicine, can alleviate the symptoms of COPD by reducing oxidative stress-mediated inflammation. However, the active components of BYF remain unclear. We developed an efficient ultrahigh-performance liquid chromatography Q-Extractive Orbitrap mass spectrometry method to identify the composition of BYF and determine its antioxidant profile through an offline screening strategy based on 1,1-diphenyl-2-trinitrophenylhydrazine (DPPH)-liquid chromatography-mass spectrometry. In total, 189 compounds were identified in BYF extract, including 83 flavonoids, 24 lignans, 20 alkaloids, 15 saponins, 11 terpenoid, 10 saccharides, eight lipids, seven organic acids, two coumarins, two amino acids, and seven other compounds. Among them, 79 compounds were found to have a potential antioxidant activity. validation indicated that the free radical scavenging activities of rosmarinic acid and calycosin were similar to that of the positive control (DPPH IC = 25.72 ± 1.02 and 147.23 ± 25.12 g/mL, respectively). Furthermore, calycosin had a high content in serum after the oral administration of BYF, indicating that calycosin might be the major antioxidant compound in BYF.

摘要

慢性阻塞性肺疾病(COPD)发病率和死亡率高,对全球人类健康构成威胁。大量临床试验证实,中药补肺益肾方(BYF)可通过减轻氧化应激介导的炎症来缓解COPD症状。然而,BYF的活性成分尚不清楚。我们开发了一种高效的超高效液相色谱Q-萃取轨道阱质谱法,通过基于1,1-二苯基-2-三硝基苯肼(DPPH)-液相色谱-质谱的离线筛选策略来鉴定BYF的成分并确定其抗氧化特性。在BYF提取物中总共鉴定出189种化合物,包括83种黄酮类化合物、24种木脂素、20种生物碱、15种皂苷、11种萜类化合物、10种糖类、8种脂质、7种有机酸、2种香豆素、2种氨基酸和7种其他化合物。其中,发现79种化合物具有潜在的抗氧化活性。验证表明,迷迭香酸和毛蕊异黄酮的自由基清除活性与阳性对照相似(DPPH IC分别为25.72±1.02和147.23±25.12μg/mL)。此外,口服BYF后血清中毛蕊异黄酮含量较高,表明毛蕊异黄酮可能是BYF中的主要抗氧化化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60c8/9588378/46ab8714cc94/IJAC2022-1423801.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60c8/9588378/1ee67158fd29/IJAC2022-1423801.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60c8/9588378/5ad69deb7dea/IJAC2022-1423801.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60c8/9588378/d9e91e810f58/IJAC2022-1423801.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60c8/9588378/46ab8714cc94/IJAC2022-1423801.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60c8/9588378/1ee67158fd29/IJAC2022-1423801.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60c8/9588378/5ad69deb7dea/IJAC2022-1423801.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60c8/9588378/d9e91e810f58/IJAC2022-1423801.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60c8/9588378/46ab8714cc94/IJAC2022-1423801.004.jpg

相似文献

1
Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS.基于离线DPPH超高效液相色谱Q-萃取轨道阱质谱联用技术的补肺益肾方化学鉴定及抗氧化筛选
Int J Anal Chem. 2022 Oct 15;2022:1423801. doi: 10.1155/2022/1423801. eCollection 2022.
2
Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling.补肺益肾方 II 的有效成分配伍通过调控 EGFR/PI3K/mTOR 信号通路抑制慢性阻塞性肺疾病大鼠的黏液高分泌
J Ethnopharmacol. 2020 Jul 15;257:112796. doi: 10.1016/j.jep.2020.112796. Epub 2020 Apr 25.
3
Identification of Metabolites and Metabolic Pathways Related to Treatment with Bufei Yishen Formula in a Rat COPD Model Using HPLC Q-TOF/MS.使用高效液相色谱-四极杆飞行时间质谱联用技术(HPLC Q-TOF/MS)在大鼠慢性阻塞性肺疾病(COPD)模型中鉴定与补肺益肾方治疗相关的代谢物和代谢途径
Evid Based Complement Alternat Med. 2015;2015:956750. doi: 10.1155/2015/956750. Epub 2015 Jun 15.
4
Effective-constituent compatibility-based analysis of Bufei Yishen formula, a traditional herbal compound as an effective treatment for chronic obstructive pulmonary disease.基于有效成分兼容性分析的补肺益肾方(一种治疗慢性阻塞性肺疾病的传统中药复方)。
J Integr Med. 2020 Jul;18(4):351-362. doi: 10.1016/j.joim.2020.04.004. Epub 2020 May 28.
5
Chemical Analysis and Multi-Component Determination in Chinese Medicine Preparation Bupi Yishen Formula Using Ultra-High Performance Liquid Chromatography With Linear Ion Trap-Orbitrap Mass Spectrometry and Triple-Quadrupole Tandem Mass Spectrometry.基于超高效液相色谱-线性离子阱-静电场轨道阱质谱联用及三重四极杆串联质谱法的中药制剂补脾益肾方的化学分析与多成分测定
Front Pharmacol. 2018 Jun 8;9:568. doi: 10.3389/fphar.2018.00568. eCollection 2018.
6
Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway.补肺益肾方 III 通过促进 NRF2/PINK1 通路介导的自噬来改善气道上皮细胞衰老,从而有效改善 COPD。
BMC Pulm Med. 2022 Nov 22;22(1):434. doi: 10.1186/s12890-022-02191-9.
7
Bufei Yishen formula protects the airway epithelial barrier and ameliorates COPD by enhancing autophagy through the Sirt1/AMPK/Foxo3 signaling pathway.补肺益肾方通过Sirt1/AMPK/Foxo3信号通路增强自噬,保护气道上皮屏障并改善慢性阻塞性肺疾病。
Chin Med. 2024 Feb 28;19(1):32. doi: 10.1186/s13020-024-00905-1.
8
Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen formula.通过调节 STAT3 和 STAT5 的激活来恢复 Th17/Treg 平衡有助于补肺益肾方改善慢性阻塞性肺疾病。
J Ethnopharmacol. 2018 May 10;217:152-162. doi: 10.1016/j.jep.2018.02.023. Epub 2018 Feb 16.
9
Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease.整合转录组学、蛋白质组学、代谢组学和系统药理学数据,揭示中药补肺益肾方治疗慢性阻塞性肺疾病的治疗机制。
Mol Med Rep. 2018 Apr;17(4):5247-5257. doi: 10.3892/mmr.2018.8480. Epub 2018 Jan 25.
10
Effective-component compatibility of Bufei Yishen formula protects COPD rats against PM2.5-induced oxidative stress via miR-155/FOXO3a pathway.补肺益肾方有效成分配伍通过miR-155/FOXO3a通路保护COPD大鼠免受PM2.5诱导的氧化应激损伤。
Ecotoxicol Environ Saf. 2021 Nov 10;228:112918. doi: 10.1016/j.ecoenv.2021.112918.

引用本文的文献

1
[ Formula ameliorates inflammation in mice with chronic obstructive pulmonary disease by inhibiting the PI3K/Akt/NF-κB signaling pathway].[方剂通过抑制PI3K/Akt/NF-κB信号通路改善慢性阻塞性肺疾病小鼠的炎症反应]
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Jul 20;45(7):1409-1422. doi: 10.12122/j.issn.1673-4254.2025.07.07.
2
Bufei Yishen formula alleviates airway epithelial cell senescence in COPD by activating AMPK-Sirt1-FoxO3a pathway and promoting autophagy.补肺益肾方通过激活AMPK-Sirt1-FoxO3a通路并促进自噬来减轻慢性阻塞性肺疾病气道上皮细胞衰老。
Sci Rep. 2025 May 13;15(1):16584. doi: 10.1038/s41598-025-00746-4.
3

本文引用的文献

1
Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology.基于血清药物化学与网络药理学整合分析金水还肝方治疗肺纤维化的活性成分及作用机制。
Phytomedicine. 2022 Jul 20;102:154177. doi: 10.1016/j.phymed.2022.154177. Epub 2022 May 21.
2
Calycosin alleviates H O -induced astrocyte injury by restricting oxidative stress through the Akt/Nrf2/HO-1 signaling pathway.毛蕊异黄酮通过 Akt/Nrf2/HO-1 信号通路限制氧化应激来减轻 H2O2 诱导的星形胶质细胞损伤。
Environ Toxicol. 2022 Apr;37(4):858-867. doi: 10.1002/tox.23449. Epub 2022 Jan 6.
3
Putative Identification of 47 Compounds from Jieyu Anshen Granule and Proposal of Pharmacopeia Quality-Assessment Strategy Using TCM-Specific Library with UHPLC-Q-Exactive-Orbitrap-MS.
基于UHPLC-Q-Exactive-Orbitrap-MS联用技术的中药专用数据库对解郁安神颗粒中47种化合物的初步鉴定及药典质量评估策略的提出
ChemistryOpen. 2025 Jan;14(1):e202400046. doi: 10.1002/open.202400046. Epub 2024 Nov 21.
4
Detection of Adulterated Tablet () via In-Depth Chemical Analysis and Subsequent Reconstruction of Its Pharmacopoeia Q-Markers.通过深入的化学分析和随后对其药典 Q-标志物的重建来检测掺假的 () 片剂。
Molecules. 2024 Mar 20;29(6):1392. doi: 10.3390/molecules29061392.
5
Bufei Yishen formula protects the airway epithelial barrier and ameliorates COPD by enhancing autophagy through the Sirt1/AMPK/Foxo3 signaling pathway.补肺益肾方通过Sirt1/AMPK/Foxo3信号通路增强自噬,保护气道上皮屏障并改善慢性阻塞性肺疾病。
Chin Med. 2024 Feb 28;19(1):32. doi: 10.1186/s13020-024-00905-1.
Calycosin Alleviates Sepsis-Induced Acute Lung Injury the Inhibition of Mitochondrial ROS-Mediated Inflammasome Activation.
毛蕊异黄酮通过抑制线粒体活性氧介导的炎性小体激活减轻脓毒症诱导的急性肺损伤
Front Pharmacol. 2021 Oct 19;12:690549. doi: 10.3389/fphar.2021.690549. eCollection 2021.
4
Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease Activation of the Adenosine 2a Receptor.补肺益肾方恢复Th17/Treg平衡并减轻慢性阻塞性肺疾病中腺苷2a受体的激活。
Front Pharmacol. 2020 Aug 7;11:1212. doi: 10.3389/fphar.2020.01212. eCollection 2020.
5
An Off-Line DPPH-GC-MS Coupling Countercurrent Chromatography Method for Screening, Identification, and Separation of Antioxidant Compounds in Essential Oil.一种用于精油中抗氧化化合物筛选、鉴定和分离的离线DPPH-GC-MS联用逆流色谱法
Antioxidants (Basel). 2020 Aug 3;9(8):702. doi: 10.3390/antiox9080702.
6
The Antioxidant Rosmarinic Acid Ameliorates Oxidative Lung Damage in Experimental Allergic Asthma via Modulation of NADPH Oxidases and Antioxidant Enzymes.抗氧化剂迷迭香酸通过调节 NADPH 氧化酶和抗氧化酶改善实验性变应性哮喘的氧化肺损伤。
Inflammation. 2020 Oct;43(5):1902-1912. doi: 10.1007/s10753-020-01264-3.
7
Mechanism of antioxidant properties of quercetin and quercetin-DNA complex.槲皮素及槲皮素 - DNA 复合物的抗氧化特性机制。
J Mol Model. 2020 May 12;26(6):133. doi: 10.1007/s00894-020-04356-x.
8
The chemical transformations for Radix Astragali via different alkaline wash conditions by quantitative and qualitative analyses.通过定量和定性分析,研究了不同堿洗条件下黄芪的化学转化。
J Pharm Biomed Anal. 2020 Jun 5;185:113164. doi: 10.1016/j.jpba.2020.113164. Epub 2020 Feb 20.
9
Characterization of phytochemicals in the roots of wild herbaceous peonies from China and screening for medicinal resources.中国野生草本牡丹根的化学成分特征及其药用资源的筛选。
Phytochemistry. 2020 Jun;174:112331. doi: 10.1016/j.phytochem.2020.112331. Epub 2020 Mar 5.
10
Preparative isolation of highly polar free radical inhibitor from Floccularia luteovirens using hydrophilic interaction chromatography directed by on-line HPLC-DPPH assay.采用亲水作用色谱在线 HPLC-DPPH 检测法从黄帚橐吾中分离高度极性自由基抑制剂。
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Apr 1;1142:122043. doi: 10.1016/j.jchromb.2020.122043. Epub 2020 Feb 26.